Europe Point of Care (PoC) Diagnostics Market Analysis with Growth Factors, 2025-2034

Table of Contents

    1. Introduction
        1.1. Report Description
            1.1.1.  Objectives of the Study
            1.1.2.  Market Scope
            1.1.3.  Assumptions
        1.2. Stakeholders
    2. Executive Summary
        2.1. Market Highlights
    3. Research Methodology
        3.1. Overview
            3.1.1.  Data Mining
        3.2. Data Sources
            3.2.1.  Primary Sources
            3.2.2.  Secondary Sources
    4. Europe Point of Care (PoC) Diagnostics Market Insights
        4.1. Europe Point of Care (PoC) Diagnostics Market – Market Snapshot
        4.2. Europe Point of Care (PoC) Diagnostics Market Dynamics
            4.2.1.  Drivers and Opportunities
                4.2.1.1. Growing Geriatric Population and Chronic Disease Management
                4.2.1.2. Rising Advancement and Innovation in PoC Technology
            4.2.2.  Restraints and Challenges
                4.2.2.1. High procedure costs
            4.2.3. Public opinion and privacy legal precedents
        4.3. Porter’s Five Forces Analysis
            4.3.1.  Bargaining Power of Suppliers (Moderate)
            4.3.2.  Threats of New Entrants: (Low)
            4.3.3.  Bargaining Power of Buyers (Moderate)
            4.3.4.  Threat of Substitute (Moderate)
            4.3.5.  Rivalry among existing firms (High)
        4.4. PESTEL Analysis
        4.5. Europe Point of Care (PoC) Diagnostics Market Trends
        4.6. Value Chain Analysis
    5. Europe Point of Care (PoC) Diagnostics Market, By Product
        5.1. Key Findings
        5.2. Introduction
            5.2.1. Europe Point of Care (PoC) Diagnostics Market, By Product, by Country, 2020–2034 (USD Billion)
        5.3. Glucose Testing
            5.3.1. Europe Point of Care (PoC) Diagnostics Market, by Glucose Testing, by Country, 2020–2034 (USD Billion)
        5.4. Hb1Ac Testing
            5.4.1. Europe Point of Care (PoC) Diagnostics Market, by Hb1Ac Testing, by Country, 2020–2034 (USD Billion)
        5.5. Coagulation
            5.5.1. Europe Point of Care (PoC) Diagnostics Market, by Coagulation, by Country, 2020–2034 (USD Billion)
        5.6. Fertility
            5.6.1. Europe Point of Care (PoC) Diagnostics Market, by Fertility, by Country, 2020–2034 (USD Billion)
        5.7. Infectious Diseases
            5.7.1. Europe Point of Care (PoC) Diagnostics Market, by Infectious Diseases, by Country, 2020–2034 (USD Billion)
            5.7.2. HIV
                5.7.2.1. Europe Point of Care (PoC) Diagnostics Market, by HIV, by Country, 2020–2034 (USD Billion)
            5.7.3. Clostridium Difficile
                5.7.3.1. Europe Point of Care (PoC) Diagnostics Market, by Clostridium Difficile, by Country, 2020–2034 (USD Billion)
            5.7.4. HBV
                5.7.4.1. Europe Point of Care (PoC) Diagnostics Market, by HBV, by Country, 2020–2034 (USD Billion)
            5.7.5. Pneumonia or Streptococcus Associated Infections
                5.7.5.1. Europe Point of Care (PoC) Diagnostics Market, by Pneumonia or Streptococcus Associated Infections, by Country, 2020–2034 (USD Billion)
            5.7.6. Respiratory Syncytial Virus (RSV)
                5.7.6.1. Europe Point of Care (PoC) Diagnostics Market, by Respiratory Syncytial Virus (RSV), by Country, 2020–2034 (USD Billion)
            5.7.7. HPV
                5.7.7.1. Europe Point of Care (PoC) Diagnostics Market, by HPV, by Country, 2020–2034 (USD Billion)
            5.7.8. Influenza/Flu
                5.7.8.1. Europe Point of Care (PoC) Diagnostics Market, by Influenza/Flu, by Country, 2020–2034 (USD Billion)
            5.7.9. HCV
                5.7.9.1. Europe Point of Care (PoC) Diagnostics Market, by HCV, by Country, 2020–2034 (USD Billion)
            5.7.10. MRSA
                5.7.10.1. Europe Point of Care (PoC) Diagnostics Market, by MRSA, by Country, 2020–2034 (USD Billion)
            5.7.11. TB and Drug-Resistant TB
                5.7.11.1. Europe Point of Care (PoC) Diagnostics Market, by TB and Drug-Resistant TB, by Country, 2020–2034 (USD Billion)
            5.7.12. HSV
                5.7.12.1. Europe Point of Care (PoC) Diagnostics Market, by HSV, by Country, 2020–2034 (USD Billion)
            5.7.13. Others
                5.7.13.1. Europe Point of Care (PoC) Diagnostics Market, by Others, by Country, 2020–2034 (USD Billion)
        5.8. Cardiac Markers
            5.8.1. Europe Point of Care (PoC) Diagnostics Market, by Cardiac Markers, by Country, 2020–2034 (USD Billion)
        5.9. Thyroid Stimulating Hormone
            5.9.1. Europe Point of Care (PoC) Diagnostics Market, by Thyroid Stimulating Hormone, by Country, 2020–2034 (USD Billion)
        5.10. Hematology
            5.10.1. Europe Point of Care (PoC) Diagnostics Market, by Hematology, by Country, 2020–2034 (USD Billion)
        5.11. Primary Care Systems
            5.11.1. Europe Point of Care (PoC) Diagnostics Market, by Primary Care Systems, by Country, 2020–2034 (USD Billion)
        5.12. Decentralized Clinical Chemistry
            5.12.1. Europe Point of Care (PoC) Diagnostics Market, by Decentralized Clinical Chemistry, by Country, 2020–2034 (USD Billion)
        5.13. Feces
            5.13.1. Europe Point of Care (PoC) Diagnostics Market, by Feces, by Country, 2020–2034 (USD Billion)
        5.14. Lipid Testing
            5.14.1. Europe Point of Care (PoC) Diagnostics Market, by Lipid Testin, by Country, 2020–2034 (USD Billion)
        5.15. Cancer Marker
            5.15.1. Europe Point of Care (PoC) Diagnostics Market, by Cancer Marker, by Country, 2020–2034 (USD Billion)
        5.16. Blood Gas/Electrolytes
            5.16.1. Europe Point of Care (PoC) Diagnostics Market, by Blood Gas/Electrolytes, by Country, 2020–2034 (USD Billion)
        5.17. Ambulatory Chemistry
            5.17.1. Europe Point of Care (PoC) Diagnostics Market, by Ambulatory Chemistry, by Country, 2020–2034 (USD Billion)
        5.18. Drug Abuse Testing
            5.18.1. Europe Point of Care (PoC) Diagnostics Market, by Drug Abuse Testing, by Country, 2020–2034 (USD Billion)
        5.19. Urinalysis
            5.19.1. Europe Point of Care (PoC) Diagnostics Market, by Urinalysis, by Country, 2020–2034 (USD Billion)
    6. Europe Point of Care (PoC) Diagnostics Market, By Mode of Prescription
        6.1. Key Findings
        6.2. Introduction
            6.2.1. Europe Point of Care (PoC) Diagnostics Market, By Mode of Prescription, by Country, 2020–2034 (USD Billion)
        6.3. OTC
            6.3.1. Europe Point of Care (PoC) Diagnostics Market, by OTC, by Country, 2020–2034 (USD Billion)
        6.4. Prescription-based
            6.4.1. Europe Point of Care (PoC) Diagnostics Market, by Prescription-based, by Country, 2020–2034 (USD Billion)
    7. Europe Point of Care (PoC) Diagnostics Market, By End Use
        7.1.  Key Findings
        7.2.  Introduction
            7.2.1. Europe Point of Care (PoC) Diagnostics Market, By End Use, by Country, 2020–2034 (USD Billion)
        7.3. Clinics
            7.3.1. Europe Point of Care (PoC) Diagnostics Market, by Clinics, by Country, 2020–2034 (USD Billion)
            7.3.2. Physician Office
                7.3.2.1. Europe Point of Care (PoC) Diagnostics Market, by Physician Office, by Country, 2020–2034 (USD Billion)
            7.3.3. Pharmacy & Retail Clinics
                7.3.3.1. Europe Point of Care (PoC) Diagnostics Market, by Pharmacy & Retail Clinics, by Country, 2020–2034 (USD Billion)
            7.3.4. Non-practice Clinics
                7.3.4.1. Europe Point of Care (PoC) Diagnostics Market, by Non-Practice Clinics, by Country, 2020–2034 (USD Billion)
            7.3.5. Urgent Care Clinic
                7.3.5.1. Europe Point of Care (PoC) Diagnostics Market, by Urgent Care Clinic, by Country, 2020–2034 (USD Billion)
        7.4. Hospitals
            7.4.1. Europe Point of Care (PoC) Diagnostics Market, by Hospitals, by Country, 2020–2034 (USD Billion)
        7.5. Home
            7.5.1. Europe Point of Care (PoC) Diagnostics Market, by Home, by Country, 2020–2034 (USD Billion)
        7.6. Assisted Living Healthcare Facilities
            7.6.1. Europe Point of Care (PoC) Diagnostics Market, by Assisted Living Healthcare Facilities, by Country, 2020–2034 (USD Billion)
        7.7. Laboratory
            7.7.1. Europe Point of Care (PoC) Diagnostics Market, by Laboratory, by Country, 2020–2034 (USD Billion)
    8. Europe Point-of-Care (PoC) Diagnostics Market
        8.1. Key Findings
        8.2. Introduction
            8.2.1. Europe Point of Care (PoC) Diagnostics Market Assessment, By Geography, by Country, 2020-2034 (USD Billion)
        8.3. Europe Point of Care (PoC) Diagnostics Market – Europe
            8.3.1. Europe: Point of Care (PoC) Diagnostics Market, by Product Type, by Country, 2020-2034 (USD Billion)
            8.3.2. Europe: Point of Care (PoC) Diagnostics Market, by Pollutant, by Country, 2020-2034 (USD Billion)
            8.3.3. Europe: Point of Care (PoC) Diagnostics Market, by End Use, by Country, 2020-2034 (USD Billion)
            8.3.4. Point of Care (PoC) Diagnostics Market – UK
                8.3.4.1. UK: Point of Care (PoC) Diagnostics Market, by Product Type, by Country, 2020-2034 (USD Billion)
                8.3.4.2. UK: Point of Care (PoC) Diagnostics Market, by Pollutant, by Country, 2020-2034 (USD Billion)
                8.3.4.3. UK: Point of Care (PoC) Diagnostics Market, by End Use, by Country, 2020-2034 (USD Billion)
            8.3.5. Point of Care (PoC) Diagnostics Market – France
                8.3.5.1. France: Point of Care (PoC) Diagnostics Market, by Product Type, by Country, 2020-2034 (USD Billion)
                8.3.5.2. France: Point of Care (PoC) Diagnostics Market, by Pollutant, by Country, 2020-2034 (USD Billion)
                8.3.5.3. France: Point of Care (PoC) Diagnostics Market, by End Use, by Country, 2020-2034 (USD Billion)
            8.3.6. Point of Care (PoC) Diagnostics Market – Germany
                8.3.6.1. Germany: Point of Care (PoC) Diagnostics Market, by Product Type, by Country, 2020-2034 (USD Billion)
                8.3.6.2. Germany: Point of Care (PoC) Diagnostics Market, by Pollutant, by Country, 2020-2034 (USD Billion)
                8.3.6.3. Germany: Point of Care (PoC) Diagnostics Market, by End Use, by Country, 2020-2034 (USD Billion)
            8.3.7. Point of Care (PoC) Diagnostics Market – Italy
                8.3.7.1. Italy: Point of Care (PoC) Diagnostics Market, by Product Type, by Country, 2020-2034 (USD Billion)
                8.3.7.2. Italy: Point of Care (PoC) Diagnostics Market, by Pollutant, by Country, 2020-2034 (USD Billion)
                8.3.7.3. Italy: Point of Care (PoC) Diagnostics Market, by End Use, by Country, 2020-2034 (USD Billion)
            8.3.8. Point of Care (PoC) Diagnostics Market – Spain
                8.3.8.1. Spain: Point of Care (PoC) Diagnostics Market, by Product Type, by Country, 2020-2034 (USD Billion)
                8.3.8.2. Spain: Point of Care (PoC) Diagnostics Market, by Pollutant, by Country, 2020-2034 (USD Billion)
                8.3.8.3. Spain: Point of Care (PoC) Diagnostics Market, by End Use, by Country, 2020-2034 (USD Billion)
            8.3.9. Point of Care (PoC) Diagnostics Market – Netherlands
                8.3.9.1. Netherlands: Point of Care (PoC) Diagnostics Market, by Product Type, by Country, 2020-2034 (USD Billion)
                8.3.9.2. Netherlands: Point of Care (PoC) Diagnostics Market, by Pollutant, by Country, 2020-2034 (USD Billion)
                8.3.9.3. Netherlands: Point of Care (PoC) Diagnostics Market, by End Use, by Country, 2020-2034 (USD Billion)
            8.3.10. Point of Care (PoC) Diagnostics Market – Russia
                8.3.10.1. Russia: Point of Care (PoC) Diagnostics Market, by Product Type, by Country, 2020-2034 (USD Billion)
                8.3.10.2. Russia: Point of Care (PoC) Diagnostics Market, by Pollutant, by Country, 2020-2034 (USD Billion)
                8.3.10.3. Russia: Point of Care (PoC) Diagnostics Market, by End Use, by Country, 2020-2034 (USD Billion)
            8.3.11. Point of Care (PoC) Diagnostics Market – Rest of Europe
                8.3.11.1. Rest of Europe: Point of Care (PoC) Diagnostics Market, by Product Type, by Country, 2020-2034 (USD Billion)
                8.3.11.2. Rest of Europe: Point of Care (PoC) Diagnostics Market, by Pollutant, by Country, 2020-2034 (USD Billion)
        8.4. Rest of Europe: Point of Care (PoC) Diagnostics Market, by End Use, by Country, 2020-2034 (USD Billion)
    9. Competitive Landscape
        9.1. Expansion and Acquisition Analysis
            9.1.1. Expansion
            9.1.2. Acquisitions
        9.2. Partnerships/Collaborations/Agreements/Exhibitions
    10. Company Profiles
        10.1. bioMérieux
            10.1.1. Company Overview
            10.1.2. Financial Performance
            10.1.3. Product Benchmarking
            10.1.4. Recent Development
        10.2. Boditech Med Inc.
            10.2.1. Company Overview
            10.2.2. Financial Performance
            10.2.3. Product Benchmarking
            10.2.4. Recent Development
        10.3. EKF Diagnostics
            10.3.1. Company Overview
            10.3.2. Financial Performance
            10.3.3. Product Benchmarking
            10.3.4. Recent Development
        10.4. Grifols
            10.4.1. Company Overview
            10.4.2. Financial Performance
            10.4.3. Product Benchmarking
            10.4.4. Recent Development
        10.5. HORIBA, Ltd. (HORIBA ABX SAS)
            10.5.1. Company Overview
            10.5.2. Financial Performance
            10.5.3. Product Benchmarking
            10.5.4. Recent Development
        10.6. Nova Biomedical
            10.6.1. Company Overview
            10.6.2. Financial Performance
            10.6.3. Product Benchmarking
            10.6.4. Recent Development
        10.7. Qiagen
            10.7.1. Company Overview
            10.7.2. Financial Performance
            10.7.3. Product Benchmarking
            10.7.4. Recent Development
        10.8. Roche Diagnostics
            10.8.1. Company Overview
            10.8.2. Financial Performance
            10.8.3. Product Benchmarking
            10.8.4. Recent Development
        10.9. Siemens Healthineers
            10.9.1. Company Overview
            10.9.2. Financial Performance
            10.9.3. Product Benchmarking
            10.9.4. Recent Development
        10.10. Werfen
            10.10.1. Company Overview
            10.10.2. Financial Performance
            10.10.3. Product Benchmarking
            10.10.4. Recent Development

    List of Tables:

    Table 1 US: Point-of-Care (PoC) diagnostics Market, by Product, by Country, 2020-2034 (USD Billion)
    Table 2 US: Point-of-Care (PoC) diagnostics Market, by Mode of Prescription, by Country, 2020-2034 (USD Billion)
    Table 3 US: Point-of-Care (PoC) diagnostics Market, by End Use, by Country, 2020-2034 (USD Billion)

    List of Figures:

    Figure 1. Europe Point of Care (PoC) Diagnostics Market, by Country, 2020–2034 (USD Billion)
    Figure 2. Integrated Ecosystem
    Figure 3. Research Methodology: Top-Down & Bottom-Up Price
    Figure 4. Market by Geography
    Figure 5. Porter’s Five Forces
    Figure 6. Market by Product
    Figure 7. Europe Point of Care (PoC) Diagnostics Market, By Product, 2024 & 2034 (USD Billion)
    Figure 8. Market by Mode of Prescription
    Figure 9. Europe Point of Care (PoC) Diagnostics Market, By Mode of Prescription, 2024 & 2034 (USD Billion)
    Figure 10. Market by End Use
    Figure 11. Europe Point of Care (PoC) Diagnostics Market, By End Use, 2024 & 2034 (USD Billion)